(Q78402091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Effects of interferon-alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

2

A Yndestad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

5

J K Damås

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

9

S S Frøland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

8

P Aukrust

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

Liv Ingunn Bjoner Sikkeland

14 December 2019

3

object named as

L I Sikkeland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

author name string

E Stylianou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

V Bjerkeli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

T Haug

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

H G Eiken

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

279-285

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12390316%20AND%20SRC:MED&resulttype=core&format=json

How cells respond to interferons

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Interferons in the pathogenesis and treatment of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Interferons in the persistence, pathogenesis, and treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Effects of interferon-alpha on a reduced release of interleukin-8 from latently HIV-1-infected monocytic cell line U937 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Immune-based therapeutics: scientific rationale and the promising approaches to the treatment of the human immunodeficiency virus-infected individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

A randomized trial of interferon alpha therapy for HIV type 1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFN alpha: results from the Primoferon A (ANRS 086) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Impaired in vitro survival of monocytes from patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

A novel method for real time quantitative RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

The immunopathogenesis of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

The TNF and TNF receptor superfamilies: integrating mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Induction of Fas ligand-mediated apoptosis by interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Apoptosis-induced by TRAIL AND TNF-alpha in human multiple myeloma cells is not blocked by BCL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells: A gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2002.01980.X

Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.

21 January 2018

1 reference

12 December 2020

Inhibition of angiogenesis by type I interferons in models of Kaposi's sarcoma.

1 reference

12 December 2020

APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death

1 reference

12 December 2020

CXC chemokines in angiogenesis.

1 reference

12 December 2020

Mechanisms of HIV-associated lymphocyte apoptosis

1 reference

12 December 2020

1 reference

12 December 2020

TRAIL/Apo-2-ligand-induced apoptosis in human T cells.

1 reference

12 December 2020